Comparison of the effects of stepwise intracranial decompression and decompressive craniectomy in the treatment of severe traumatic brain injury: A randomized controlled trial Authors: Chunbo Liu, Geng Jia, Ruhong Wu, Changchun Yang Published: 2023 ABSTRACT Background:To compare the effects of stepwise intracranial decompression (SID) and decompressive craniectomy (DC) on severe traumatic brain injury.Methods:This prospective randomized study was conducted at The Third Affiliated Hospital of Soochow University. Ninety two patients were divided into 2 groups according to the random number table method. The study group received SID, whereas the control group received DC. The surgical time and intraoperative bleeding of the 2 groups of patients were recorded, neurological function and glasgow coma score before and after treatment in both groups, incidence of complications, prognostic situation, and levels of brain oxygen metabolism indicators before and after treatment.Results:Among the 92 patients who agreed, 46 were assigned to the study and control groups, and 6 patients were excluded. Finally, 86 patients were analyzed, including 43 in the study group and 43 in the control group. After treatment, the glasgow coma score scores of the 2 groups increased compared to before treatment; the study group had a higher score, The National Institutes of Health Stroke Scale score decreased compared to before treatment, and the study group had a lower score (P < .05). The incidence of complications in the study group (4.65%) was significantly lower than that in the control group (18.60%) (P < .05). The good prognosis rate of the research group (41.86%) was significantly higher than that of the control group (16.28%) (P < .05).Conclusion:Compared with DC, using SID to treat severe traumatic brain injury can shorten surgical time and reduce intraoperative bleeding, more effectively improve patients neurological function and consciousness state, reduce the incidence of complications, and regulate brain oxygen metabolism status, which is beneficial for improving prognosis and ensuring a good outcome of the disease. 1. Introduction Severe head injury is caused by strong external violence in the brain and is characterized by sudden onset, severe illness, and rapid progression.[1] At the same time, severe traumatic brain injury often presents with varying degrees of elevated intracranial pressure, manifested as consciousness disorders, vomiting, nausea, severe headaches, and high disability and mortality rates, posing a huge threat to the patient’s life and health.[1,2] Surgery is currently an important measure in the clinical treatment of severe traumatic brain injuries.[3] Although traditional craniotomy can reduce intracranial pressure, alleviate the degree of brain edema, and alleviate clinical symptoms in patients.[4] However, owing to the poor stability of intracranial pressure in patients and a sudden decrease in intracranial pressure during treatment, traditional craniotomy surgery is prone to many complications, which is not conducive to a good prognosis of the disease.[4,5] Stepwise intracranial decompression (SID) can be treated by gradually reducing intracranial pressure while ensuring a steady decrease in intracranial pressure, which has positive significance in improving the effectiveness and safety of surgical treatment.[6,7] However, there is limited literature comparing the efficacy of controlled stepwise decompression with traditional decompressive craniectomy (DC) for the treatment of severe brain injury. Based on this, this study selected 92 patients with severe head injury in our hospital and compared the efficacy of SID and DC in the treatment of severe head injury in a randomized controlled trial. We intended to provide references and suggestions to relevant clinical workers. 2. Materials and methods 2.1. Study design This was a single-center, prospective, randomized controlled trial. The study was approved by the Medical Ethics Committee of the Third Affiliated Hospital of Soochow University (number: CYL20220312; Date: April 23, 2022) and followed the Helsinki Declaration. Written informed consent was obtained from all participating patients prior to inclusion in the study. 2.2. General data 92 patients with severe head injury who received treatment at The Third Affiliated Hospital of Soochow University from January 2020 to January 2023 were selected. 2.2.1. Inclusion criteria. Meets the diagnostic criteria for severe head injury[8]. Meets the diagnostic criteria for severe head injury[8]. There is a clear history of trauma in the brain. There is a clear history of trauma in the brain. The glasgow coma score (GCS) score is 3 to 8 points. The glasgow coma score (GCS) score is 3 to 8 points. 2.2.2. Exclusion criteria. Patients with other cerebrovascular diseases. Patients with other cerebrovascular diseases. Patients with primary brain stem injury. Patients with primary brain stem injury. Patients with coagulation disorders. Patients with coagulation disorders. Patients with multiple organ failure and hemorrhagic shock. Patients with multiple organ failure and hemorrhagic shock. Previous history of cerebral infarction and tumors. Previous history of cerebral infarction and tumors. The pupils on both sides continue to dilate. The pupils on both sides continue to dilate. 2.3. Random grouping All subjects were divided into study and control groups using a computer-generated random number table, with 46 cases in each group. Randomization was centralized and computer-generated, with each patient having a unique randomization number (patient code). The treatment task is hidden from patients, nonmedical researchers, and statisticians. 2.4. Surgery method 2.4.1. Study group. Take SID. General anesthesia. The forehead and temporal scalp were cut to the skull and the periosteum was quickly peeled off, a hole was drilled at the projection of the skull, the dura mater was cut, and an intracranial pressure monitoring probe was placed under the dura mater; controlled release of partial hemorrhagic cerebrospinal fluid and intracranial hematoma; removal of the bone flap; removal of the sphenoid ridge through bone rongeur biting, intravenous injection of 40 to 80 mg of furosemide and 250 mL of mannitol (20%), excessive ventilation, increased oxygen concentration, reduced intracranial pressure, and several small incisions were made in the blue area under the dura mater; slowly release the bleeding and swelling; and make a curved incision on the dura mater around the lateral fissure, by placing an intracranial pressure monitoring probe at the base of the skull through the lateral fissure, slowly release the bloody cerebrospinal fluid and surrounding hematoma at the lateral fissure site, and slowly reduce intracranial pressure; If the intracranial pressure drops below 20 mm Hg, the dura mater should be radially cut open to clean the inactive brain tissue and intracranial hematoma. If necessary, some of the hippocampal sulcus and gyrus brain tissue should be cut off from the temporal pole. If the intracranial pressure is still ≥ 20 mm Hg, the brain tissue in the nonfunctional area of the temporal/frontal lobes will be removed. After the intracranial pressure drops below 20 mm Hg, decompression repair and suturing of the dura mater are performed through the temporal muscle fascia and artificial dura mater. Routine placement of drainage tubes. Close the brain. 2.4.2. Control group. Adopt DC. General anesthesia. A surgical incision was made on the upper edge of the zygomatic arch about 1 cm in front of the affected earlobe, from the posterior and superior to the top tubercle, and from the anterior to the forehead and temples, until the top midline; filling open bone flap from the zygomatic process of the frontal bone (15 cm × 12 cm); decompression of the anterior edge of the bone window to the frontal pole; maximum removal of the sphenoid ridge; full exposure of the sphenoid plateau; radial incision of the dura mater; sufficient decompression; and clearance of inactive brain tissue and hematoma. Effectively stopped bleeding, suspended the dura mater around the bone margin, and sutured the dura mater with reduced tension. Close the incision. 2.5. Outcome measures The neurological function and GCS scores of the 2 groups were calculated before and 1 month after treatment.[9] The neurological function was evaluated using the National Institutes of Health Stroke Scale (NIHSS), with a score range of 0 to 42 points. The higher the score, the worse the neurological function.[10] The GCS range is 3 to 15 points, and the higher the score, the better the state of consciousness;[11] Calculate the incidence of complications was calculated in both groups; According to the glasgow outcome scale, the prognosis of the 2 groups at 6 months after surgery was evaluated, with a score of 5 indicating good prognosis, 4 indicating mild disability, 3 indicating severe disability, 2 indicating vegetative survival, and 1 indicating death;[12] Two groups of cerebral oxygen metabolism indicators [internal jugular bulb venous oxygen saturation (SjvO2), internal jugular vein oxygen content (CjvO2), internal carotid artery oxygen content (CaO2), and cerebral oxygen uptake rate (CERO2)] were measured before and one month after treatment using the Japanese PULSOX-1 blood oxygen saturation monitor. 2.6. Statistical analysis All data analyses were conducted using the SPSS software (version 20.0; IBM Corp., Armonk, NY). The normality of the data was evaluated using the Shapiro–Wilk test. The data of normal distribution are represented by mean ± standard deviation. Independent sample t test was used for inter-group comparison, and paired t test was used for intragroup comparison before and after. Non-normal distribution data are represented by median and interquartile intervals. The Mann–Whitney U test was used for inter-group comparison, and the Wilcoxon signed rank test was used for intragroup comparison before and after. Counting data are represented by the number of use cases using the chi-square test. When P < .05, the Differences were considered statistically significant at P < .05. 3. Results From January 2020 to January 2023, we recruited 92 patients who agreed to participate, with 46 patients assigned to the study group and 6 patients excluded from the control group. Finally, 86 patients were analyzed, including 43 in the study group and 43 in the control group (Fig. 1). There was no significant difference in baseline data between the 2 groups (P > .05) (Table 1). The observation group had significantly shorter intracranial decompression and surgery times than the control group, with statistically significant differences (P < .05), and the intraoperative bleeding volume in the observation group was significantly lower than that in the control group (P < .05) (Table 2). There was no significant difference in the NIHSS and GCS scores between the 2 groups before treatment (P > .05). One month after treatment, the GCS scores of the 2 groups increased compared to before treatment, and the study group was significantly higher than the control group. The NIHSS score decreased compared to before treatment, and the study group was significantly lower than the control group (P < .05) (Table 3). The incidence of complications in the study group (4.65%) was significantly lower than that in the control group (18.60%) (P < .05) (Table 4). The good prognosis rate in the research group (41.86%) was significantly higher than that in the control group (16.28%) (P < .05) (Table 5). Before treatment, there was no significant difference between the 2 groups in SjvO2, CjvO2, CaO2, and CERO2 (P > .05); One month after treatment, SjvO2, CjvO2, and CERO2 in both groups increased compared to before treatment, and the study group was significantly higher than the control group. CaO2 decreased compared to before treatment, and the study group was significantly lower than the control group (P < .05) (Table 6). Table 1Comparison of baseline data between two groups.Basic informationStudy group (n = 43)Control group (n = 43) χ2/t P valueGender (male/female)25/1819/241675.196Age (yr)51.14 ± 8.4850.53 ± 7.99−0.340.734BMI (kg/m²)24.83 ± 2.3125.15 ± 2.90−0.5592.578Occurred at the time of admission3.49 ± 1.453.64 ± 1.58−0.462.645Hypertension [yes, n (%)]9 (20.93)7 (16.28)0.307.579Diabetes [yes, n (%)]4 (9.30)5 (11.63)0.124.725Smoking history [yes, n (%)]12 (27.91)15 (34.88)0.486.486 Comparison of baseline data between two groups. Table 2Comparison of surgical conditions between two groups.GroupInitial intracranial decompression time (min)Surgical time (min)Intraoperative bleeding volume (mL)Study group10.14 ± 4.0384.05 ± 12.10107.09 ± 26.54Control group36.60 ± 6.99106.91 ± 16.49123.19 ± 28.15 t −21.496−7.330−2.728P value<.001<.001.008 Comparison of surgical conditions between two groups. Table 3Comparison of NIHSS and GCS scores between two groups (points).TimeGroupnGCSNIHSSBefore treatmentStudy group435 (4–6)26 (24–31)Control group435 (5–6)25 (24–28) Z −1.409−0.903P value.159.366One month after treatmentStudy group4310 (9–11)*17 (16–19)*Control group439 (8–10)*20 (19–23)* Z −2.363−4.091P value.018<.001Compared with the same group before treatment.GCS = glasgow coma score, NIHSS = National Institutes of Health Stroke Scale.*P < .05. Comparison of NIHSS and GCS scores between two groups (points). Compared with the same group before treatment. GCS = glasgow coma score, NIHSS = National Institutes of Health Stroke Scale. P < .05. Table 4Comparison of the incidence of complications between two groups.GroupnCerebral infarctionDelayed hematomaAcute encephaloceleHyponatremiaTotal occurrence rateStudy group430 (0.00)1 (2.33)0 (0.00)1 (2.33)2 (4.65)Control group431 (2.33)3 (6.98)2 (4.65)2 (4.65)8 (18.60) χ2 4.074P value.044 Comparison of the incidence of complications between two groups. Table 5Comparison of prognosis between two groups.GroupnGood prognosisMild disabilitySevere disabilityPlant SurvivalDeathStudy group4318 (41.86)13 (30.23)7 (16.28)4 (9.30)1 (2.33)Control group437 (16.28)14 (32.56)9 (20.93)8 (18.60)5 (11.63) χ2 6.8240.0540.3071.5501.613P value.009.816.579.213.204 Comparison of prognosis between two groups. Table 6Comparison of brain oxygen metabolism indicators between two groups.TimeGroupnSjvO2 (%)CjvO2 (mL/L)CaO2 (mL/L)CERO2 (%)Before treatmentStudy group4347.56 ± 5.6188.30 ± 9.42172.23 ± 12.2928.02 ± 3.20Control group4346.88 ± 5.1586.53 ± 10.73169.44 ± 13.2728.93 ± 3.79 t 0.5810.8121.012−1.198P value.563.419.314.234One month after treatmentStudy group4368.56 ± 6.55a108.81 ± 11.54121.16 ± 11.99*44.44 ± 5.46*Control group4358.58 ± 6.13*96.12 ± 10.66*130.12 ± 12.49*36.91 ± 4.55* t 7.2875.298−3.3916.957P value<.001<.001.001<.001Compared with the same group before treatment.CaO2 = internal carotid artery oxygen content, CERO2 = cerebral oxygen uptake rate, CjvO2 = internal jugular vein oxygen content, SjvO2 = internal jugular bulb venous oxygen saturation.*P < .05. Comparison of brain oxygen metabolism indicators between two groups. Compared with the same group before treatment. CaO2 = internal carotid artery oxygen content, CERO2 = cerebral oxygen uptake rate, CjvO2 = internal jugular vein oxygen content, SjvO2 = internal jugular bulb venous oxygen saturation. P < .05. Guidelines flow diagram. 4. Discussion The results of this study indicate that compared to DC, SID has a higher application value in severe brain injury and is more helpful in ensuring good disease outcomes. The main reason for this is that traditional craniotomy methods can yield certain results. However, during the treatment period, it is extremely easy to cause a sharp decrease in intracranial pressure owing to rapid decompression, and the pressure packing effect suddenly disappears. This can easily lead to large-scale cerebral infarction, bone window brain tissue incarceration, delayed cerebral hematoma, and malignant encephalocele, thereby affecting the prognosis of the disease.[13] In SID, through appropriate controlled stepwise decompression, it is possible to prevent or reduce the occurrence of delayed cerebral hematoma by avoiding the sudden disappearance of the tamponade effect, resulting in dural detachment, damage to reflux venous vessels, etc.[13,14] Meanwhile, Zhang et al[15] pointed out in their study that due to the segmented, multiple, and gradual mesh-like opening of the dura mater, the stepwise decrease in brain pressure can prevent significant displacement of brain tissue, thereby avoiding the occurrence of local cerebral hernia, and there is no rapid displacement of the brain tissue. It does not cause further deformation, distortion, or stretching of the cerebral blood vessels, thus preventing the occurrence of large-scale cerebral infarction. It has also been confirmed that controlled decompression is beneficial for reducing the degree of brain edema and neuronal damage in patients, ensuring neurological recovery and improving the prognosis of the disease. This finding is consistent with the conclusions of the present study. Chen et al[16] pointed out that multiple reticular incisions of the dura mater in SID play a positive role in preventing or reducing malignant encephaloceles. It can effectively prevent a sudden decrease in intracranial pressure, cerebral reperfusion injury, and excessive dilation of cerebral blood vessels caused by routine rapid cutting of the dura mater, thereby achieving the goal of controlled balanced hypotension. After radial cutting of the dura mater, necrotic brain tissue and residual hematoma must be quickly removed to achieve internal decompression.[15,16] However, it is necessary to ensure that the dural incision is as far away from the lateral fissure blood vessels as possible and to carry out treatment operations in the lateral fissure area as carefully and gently as possible to avoid compression of the lateral fissure blood vessels caused by the dural incision. Effective protection should be provided to lateral fissure blood vessels to prevent blood reflux and reduce the risk of cerebral infarction and venous congestion.[16] Chen J et al[17] found that compared to rapid decompression surgery, controlled decompression surgery can reduce the 30-day all-cause mortality rate from 30.8% to 18.6%, while the brain swelling, delayed hematoma, and cerebral infarction rates can be reduced from 24.3%, 29.0%, and 22.4% to 13.3%, 17.7%, and 15.0%, respectively, which helps to ensure good disease outcomes. This finding is consistent with the results of the present study. Qian et al[18] confirmed that SID can ensure good disease outcomes by alleviating inflammatory reactions in the brain and inhibiting necrosis and apoptosis in brain tissue.[19,20] SjvO2, CjvO2, CaO2, and CERO2 are important indicators for the clinical evaluation of brain oxygen metabolism status. The results of this study showed that after treatment, the SjvO2, CjvO2, and CERO2 levels in the study group were higher than those in the control group, while the CaO2 levels were lower than those in the control group. This indicates that SID can also help regulate the cerebral oxygen metabolism status of patients with severe head injury, mainly because this surgical method can slowly, stably, and continuously reduce intracranial pressure, not only without damaging cerebral blood vessels but also has a certain protective effect on them. To ensure rapid recovery of the brain blood supply for postoperative patients, reduce brain nerve function damage, and ensure the prognosis and outcome of the disease. 5. Limitations Belonging to a single-center study with a small sample size, the researchers did not use blind methods in the study but did not participate in recording data. Second, the follow-up time was short; therefore, multiple centers, large sample sizes, and long-term follow-up are needed to verify the results of this study. 6. Conclusion Compared with DC, using SID to treat severe traumatic brain injury can shorten surgical time, reduce intraoperative bleeding, improve neurological function and consciousness, reduce the incidence of complications, regulate cerebral oxygen metabolism, and improve prognosis, ensuring good disease outcomes. Author contributions Conceptualization: Chunbo Liu. Data curation: Geng Jia. Formal analysis: Ruhong Wu. Writing – original draft: Chunbo Liu. Writing – review & editing: Changchun Yang.